日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Rezivertinib in EGFR-Mutated Non-Small Cell Lung Cancer Patients with Central Nervous System Metastasis: Central Nervous System Efficacy from the Phase III REZOR Study

瑞维替尼治疗伴有中枢神经系统转移的EGFR突变型非小细胞肺癌患者:来自III期REZOR研究的中枢神经系统疗效

Yang, Sheng; Zhao, Yanqiu; Sun, Meili; Bi, Minghong; Zhu, Bo; Chen, Zhaohong; Yu, Huiqing; Zhang, Liangming; Wu, Lin; Zhou, Rui; Yao, Wenxiu; Li, Xingya; Han, Zhigang; Wang, Ke; Wang, Lijun; Wen, Meiling; Guo, Yanzhen; Lin, Yingcheng; Sun, Shenghua; Guo, Shuliang; Yi, Tienan; Zhao, Wenhua; Yu, Zhuang; Qin, Jianwen; Pan, Yueyin; He, Zhiyong; Ye, Feng; Shi, Huaqiu; Fang, Jian; Ma, Rui; Lu, Hong; Zhang, Hua; Shi, Jianhua; Gao, Jinghua; Cui, Jiuwei; Li, Manxiang; Yi, Shanyong; Cang, Shundong; Shu, Yongqian; Zhang, Don; Peng, Jirong; Gao, Feng; Wang, Tingting; Zhou, Anqi; Shi, Yuankai

Efficacy and safety of savolitinib in Chinese patients with locally advanced or metastatic MET exon 14-mutated non-small cell lung cancer: final results of a confirmatory Phase 3b study

savolitinib治疗局部晚期或转移性MET 14号外显子突变型非小细胞肺癌中国患者的疗效和安全性:一项确证性3b期研究的最终结果

Yu, Yongfeng; Guo, Qisen; Zhang, Yongchang; Fang, Jian; Zhong, Diansheng; Liu, Baogang; Pan, Pinhua; Lv, Dongqing; Wu, Lin; Zhao, Yanqiu; Li, Juan; Liu, Zhihua; Liu, Chunling; Su, Haichuan; Fan, Yun; Zhang, Tongmei; Liu, Anwen; Jin, Bo; Wang, Ye; Zhou, Jianying; Zhang, Zhihong; Ran, Fengming; Song, Xia; Shi, Michael M; Su, Weiguo; Lu, Shun

The alteration of bile acids and gut microbiota is associated with intestinal barrier dysfunction and inflammaging in human

胆汁酸和肠道菌群的改变与人类肠道屏障功能障碍和炎症衰老有关。

Xu, Yumei; Zhang, Liang; Li, Tianci; Zhao, Yanqiu; Wang, Shuo; Qi, Junwen; Shi, Linsen

Safety, pharmacokinetics and efficacy of HA121-28 in patients with advanced solid tumors and RET fusion-positive non-small-cell lung cancer: a multicenter, open-label, single-arm phase 1/2 trial

HA121-28 在晚期实体瘤和 RET 融合阳性非小细胞肺癌患者中的安全性、药代动力学和疗效:一项多中心、开放标签、单臂 1/2 期试验

Ruan, Dan-Yun; Huang, Wen-Wen; Li, Yongsheng; Zhao, Yanqiu; Shi, Yehui; Jia, Yuming; Cang, Shundong; Zhang, Wei; Shi, Jianhua; Chen, Jun; Lin, Jie; Liu, Yunpeng; Xu, Jianming; Ouyang, Weiwei; Fang, Jian; Zhuang, Wu; Liu, Caigang; Bu, Qing; Li, Manxiang; Meng, Xiangjiao; Sun, Meili; Yang, Nong; Dong, Xiaorong; Pan, Yueyin; Li, Xingya; Qu, Xiujuan; Zhang, Tongmei; Yuan, Xianglin; Hu, Sheng; Guo, Wei; Li, Yalun; Li, Shengqing; Liu, Dongying; Song, Feixue; Tan, Liping; Yu, Yan; Yu, Xinmin; Zang, Aimin; Sun, Chang; Zhang, Qian; Zou, Kai; Dan, Mo; Xu, Rui-Hua; Zhao, Hongyun

A B7H3-targeting antibody-drug conjugate in advanced solid tumors: a phase 1/1b trial.

针对晚期实体瘤的 B7H3 靶向抗体药物偶联物:一项 1/1b 期试验

Ma Yuxiang, Yang Yunpeng, Huang Yan, Fang Wenfeng, Xue Jinhui, Meng Xiangjiao, Fan Yun, Fu Siqing, Wu Lin, Zheng Yulong, Liu Jian, Liu Zhihua, Zhuang Wu, Rosen Seth, Qu Song, Li Bihui, Li Mingjun, Zhao Yanqiu, Yang Shujun, Ji Yinghua, Sommerhalder David, Luo Suxia, Yang Kunyu, Li Jingao, Lv Dongqing, Zhang Peng, Zhao Yuanyuan, Hong Shaodong, Zhang Yang, Zhao Shen, Chin Steve, Zhang Xian, Lian Wei, Cai Jiaqiang, Xue Tongtong, Zhang Li, Zhao Hongyun

Efficacy and safety of first-line sintilimab plus anlotinib versus chemotherapy for metastatic non-small cell lung cancer: a phase II, open-label, randomized controlled trial

一线信迪利单抗联合安罗替尼对比化疗治疗转移性非小细胞肺癌的疗效和安全性:一项II期、开放标签、随机对照试验

Chu, Tianqing; Zhong, Hua; Yu, Zhuang; Wang, Jing; Zhao, Yanqiu; Mu, Xiaoqian; Yu, Xinmin; Shi, Xun; Shi, Qingming; Guan, Maojing; Ding, Cuimin; Geng, Nan; Qian, Jialin; Han, Baohui

Efficacy and safety of glecirasib in solid tumors with KRAS G12C mutation: A pooled analysis of two phase I/II trials

glecirasib治疗KRAS G12C突变实体瘤的疗效和安全性:两项I/II期试验的汇总分析

Li, Jian; Deng, Ting; Gu, Yanhong; Calles Blanco, Antonio; Li, Zhihua; Bai, Chunmei; Wu, Lin; Huang, Jing; Li, Xingya; Yao, Yu; Song, Zhengbo; Li, Yongsheng; Liu, Lian; Xing, Ligang; Wu, Wenming; Martínez-Pérez, Julia; Hubert, Ayala; Zugazagoitia, Jon; Zhang, Jian; Wang, Yongsheng; Zhao, Yanqiu; Wen, Guilan; Xia, Guohao; Zhong, Diansheng; Chen, Xueqin; Jiang, Kuirong; Wang-Gillam, Andrea; Ding, Yuli; Liu, Sumei; Rao, Zhiyue; Liu, Xinghu; Shen, Lin

Toripalimab Plus Chemotherapy as a First-Line Therapy for Extensive-Stage Small Cell Lung Cancer: The Phase 3 EXTENTORCH Randomized Clinical Trial

托瑞普利单抗联合化疗作为广泛期小细胞肺癌的一线治疗:EXTENTORCH III期随机临床试验

Cheng, Ying; Zhang, Wei; Wu, Lin; Zhou, Caicun; Wang, Donglin; Xia, Bing; Bi, Minghong; Fu, Xiuhua; Li, Chong; Lv, Dongqing; Zhao, Yanqiu; Chen, Gongyan; Yi, Tienan; Huang, Jianan; Li, Min; Yang, Runxiang; Huang, Xiaoping; Wang, Ye; Zhang, Mingjun; Pan, Yueyin; Sun, Yilan; Hu, Sheng; Zhang, Xiqin; Zhou, Min; Fang, Jian; Jin, Faguang; Liu, Yunpeng; Li, Yinyin; Zhang, Zhihong; Hu, Jie; Liu, Laiyu; Wang, Rui; Li, Yan; Gu, Kangsheng; Ding, Cuimin; Fan, Qingxia; Zhang, Guojun; Chen, Yongxing; Jiang, Liyan; Zheng, Wei-E; Chen, Shaoshui; Huang, Cheng; Han, Zhigang; Yang, Hong; Wang, Jianfang; Wang, Baocheng; Wu, Huita; Bao, Yongxing; Li, Manxiang; Luo, Xianming; Gu, Shanshan; Yu, Wenbo; Xu, Kai; Zhang, Simo; Yu, Jianjun

Safety, pharmacokinetic, pharmacodynamic, and efficacy properties of orally administered APG-2449 in patients with advanced ALK (+) and ROS1 (+) non-small-cell lung cancer: a multicentre, open-label, single-arm phase 1 trial

口服APG-2449治疗晚期ALK(+)和ROS1(+)非小细胞肺癌患者的安全性、药代动力学、药效学和疗效:一项多中心、开放标签、单臂I期试验

Ma, Yuxiang; Song, Zhengbo; Chen, Jianhua; Zhao, Yanqiu; Fang, Wenfeng; Guo, Yubiao; Dong, Yugang; Yang, Yunpeng; Wu, Gang; Fang, Jian; Lin, Xiaoyan; Li, Jundong; Huang, Yan; Zhao, Yuanyuan; Hong, Shaodong; Xue, Jinhui; Zhang, Yang; Liu, Qianwen; Yang, Chen; Xu, Liang; Yang, Yun; Xiong, Dengkun; Yang, Dajun; Zhai, Yifan; Zhang, Li; Zhao, Hongyun

The involvement of TRPV1 in the apoptosis of spermatogenic cells in the testis of mice with cryptorchidism.

TRPV1参与隐睾小鼠睾丸生精细胞凋亡

Zhao Yanqiu, Wei Jinhua, Cheng Pang, Ma Junxian, Liu Bo, Xiong Mingxiang, Gao Ting, Yao Jingqi, Sun Tianchen, Li Zhen